SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

PYTH is trending following a major exchange listing and the introduction of a new token buyback program funded by network revenue, with the community enthusiastically discussing its potential as a leading oracle in the Real-World Assets (RWA) sector.

BlackRock Institutional Trust Company N.A. - iShares MSCI Japan ETF

iShares MSCI Japan ETF

The iShares MSCI Japan ETF (EWJ) is trending amidst significant volatility in Japanese markets, spurred by shifts in Bank of Japan policy signals and the unwinding of the yen carry trade. The community is actively discussing whether record highs and dramatic market swings signify a historic paradigm shift for Japanese equities or an unstable, liquidity-driven environment.

SPDR Series Trust - State Street SPDR S&P Aerospace & Defense ETF

SPDR S&P Aerospace & Defense ETF

The SPDR S&P Aerospace & Defense ETF ($XAR) is trending amidst intensifying global geopolitical tensions and calls for increased defense spending, with the community actively discussing its consistent outperformance as a potential safe haven.

nLIGHT, Inc. engages in the provision of semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It operates through the Laser Products and Advanced Development segments. The Laser Products segment designs, manufactures, and sells a range of semiconductor lasers and fiber lasers that are typically integrated into laser systems or manufacturing tools built by customers. The Advanced Development segment focuses on research, design, and prototyping of next-generation laser technologies, leveraging expertise in laser technology, development, beam control, and advanced optics. The company was founded by Scott H. Keeney, Mark DeVito, and Jason Farmer in June 2000 and is headquartered in Camas, WA.

nLIGHT Inc

nLIGHT Inc. is trending as the community speculates on significant defense contracts for its high-energy laser systems, including missile defense initiatives like "Golden Dome," with upcoming showcases at defense shows and recent manufacturing expansion underscoring its pivotal role in modern warfare. Bulls are particularly encouraged by the stock's resilience above a recent private offering price and multiple analyst upgrades, actively countering persistent short-seller sentiment.

ProShares Trust - ProShares Ultra Semiconductors 2X Shares

ProShares Ultra Semiconductors

Driven by relentless demand for AI chips and robust sales growth from major players like TSMC and Nvidia, the semiconductor sector continues its strong performance. ProShares Ultra Semiconductors ($USD) is actively discussed among investors for its impressive leveraged gains and strategic exposure to the booming AI-driven market.

OpGen, Inc. is a precision medicine company, which engages in the power of molecular diagnostics and informatics to help combat infectious disease. It focuses on the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Clarksburg, MD.

Opgen Inc

OPGN is trending due to its recent pivot from a struggling biotech to an AI-enabled fintech company, CapForce, which is progressing towards a full app launch and Nasdaq relisting. The community is actively discussing the stock's extremely low float and quiet accumulation, speculating on explosive growth potential fueled by increased demand and institutional interest post-relisting.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MercadoLibre is a hot topic following its Q3 report, which showed robust revenue growth driven by its e-commerce and fintech segments but missed EPS estimates due to significant investments impacting margins. While many investors remain bullish on its long-term Latin American market leadership and recent analyst upgrades, others express caution about increasing competition, continued margin pressures, and the stock's sensitivity to regional macroeconomic events like Brazil-US tariff discussions and the aftermath of Argentina's election.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron is trending as recent Q4 earnings reveal robust Dupixent growth and new drug approvals for Libtayo and Evkeeza, despite ongoing Eylea sales pressure and manufacturing delays for its pre-filled syringe, with the community actively discussing the company's strong pipeline and long-term potential amidst numerous analyst upgrades.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as investors are actively discussing its significant institutional backing, notably an increased BlackRock stake, and its partnership with NVIDIA for AI-powered air taxis. The community remains divided, however, balancing optimism for upcoming eIPP city selections and potential piloted flights against persistent concerns about delays and an ongoing legal dispute within the eVTOL sector.

Binance Coin is the cryptocurrency of the Binance platform. It is a trading platform exclusively for cryptocurrencies. The name "Binance" is a combination of binary and finance.  Thus, the startup name shows that only cryptocurrencies can be traded against each other. It is not possible to trade crypto currencies against Fiat. The platform achieved an enormous success within a very short time and is focused on worldwide market with Malta headquarters. The cryptocurrency currently has a daily trading volume of 1.5 billion - 2 billion US dollars and is still increasing.  In total, there will only be 200 million BNBs. Binance uses the ERC20 token standard from Ethereum and has distributed it as follow: 50% sold on ICO, 40% to the team and 10% to Angel investors. The coin can be used to pay fees on Binance. These include trading fees, transaction fees, listing fees and others. Binance gives you a huge discount when fees are paid in BNB.   The schedule of BNB fees discount is as follow: In the first year, 50% discount on all fees, second year 25% discount, third year 12.5% discount, fourth year 6.75 % discount, and from the fifth year onwards there is no discount. This structure is used to incentivize users to buy BNB and do trades within Binance.  Binance announced in a buyback plan that it would buy back up to 100 million BNB in Q1 2018. The coins are then burned. This means that they are devaluated to increase the value of the remaining coins. This benefits investors. In the future, the cryptocurrency will remain an asset on the trading platform and will be used as gas.  Other tokens that are issued by exchanges include Bibox Token, OKB, Huobi Token, and more.

Binance

BNB is trending due to polarized community debate around recent governance shake-ups initiated by CZ-backed YZi Labs and ongoing legal settlements for past compliance issues at Binance. While some accuse Binance of market manipulation and question its integrity, others emphasize BNB's expanding ecosystem, institutional integrations, and resilience as key drivers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Promising Small Cap Stocks To Consider - January 22nd

Spring Valley Acquisition, 60 Degrees Pharmaceuticals, and Namib Minerals are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of...

Pharmaceutical Stocks To Consider - January 22nd

Abbott Laboratories, Eli Lilly and Company, 60 Degrees Pharmaceuticals, Novo Nordisk A/S, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool...

60 Degrees Pharmaceuticals Soars After Runway Health Partnership

60 Degrees Pharmaceuticals shares are trading higher after the company announced a partnership with Runway Healthread more...

<ul class="summary-bullets"><li>Arakoda is currently the only broad-spectrum, once-weekly malaria prevention option in the U.S. for international travelers approved by the FDA, the company said.</li><li>60 Degrees stated that the partnership with Runway Health commences on April 2, 2026.</li><li>Eligible travelers will be able to align their travel itinerary with a personalized medical treatment plan designed by a licensed healthcare provider.</li></ul>60 Degrees Pharmaceuticals Inc. (SXTP) shares soared more than 161% in Thursday’s pre-market trade after the company announced a new partnership to expand access to its malaria prevention medicine.60 Degrees has partnered with Runway Health to offer international travelers access to Arakoda through the latter’s travel medicine platform.Arakoda is currently the only broad-spectrum, once-weekly malaria prevention option in the U.S. for international travelers approved by the Food and Drug Administration (FDA), the company said.<h2 class="st-heading-2">What Does The Partnership Offer?</h2>60 Degrees stated that the partnership with Runway Health commences on April 2, 2026. Eligible travelers will be able to match their travel itinerary with a personalized medical treatment plan that is designed by a licensed healthcare provider, the company said.Runway Health is a telehealth platform that offers users access to online consultations led by physicians. This direct-to-patient service allows users to consult with healthcare providers before their departure to regions of the world where certain illnesses, such as malaria, may be prevalent.After the consultation, based on the healthcare providers' advice, users will receive home delivery of the prescribed medication prior to their departure.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/SXTP">60 Degrees</a> was in the ‘extremely bullish’ territory, with message volumes at ‘extremely high’ levels.One bullish user stated they will wait for a buying opportunity in SXTP stock.<stembedurl>https://stocktwits.com/Mrmessiah/message/642530478</stembedurl><a href="https://stocktwits.com/symbol/SXTP">SXTP stock</a> is down 2% year-to-date and 88% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-greenland-piece-of-golden-dome-dow-futures-rise/cmUzUjPR4Qw">Trump Reportedly Says A Piece Of Golden Dome Will Be On Greenland — Dow Futures Rise Over 100 Points</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

SXTP Stock Rockets 161% Pre-Market — What Is Driving The Surge?

60 Degrees has partnered with Runway Health to offer international travelers access to Arakoda via Runway Health’s travel medicine platform.

Equity

Here's Why 60 Degrees Pharmaceuticals Inc. (SXTP) Looks Ripe for Bottom Fishing

60 Degrees Pharmaceuticals Inc. (SXTP) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates

Ardelyx (ARDX) delivered earnings and revenue surprises of +38.46% and +15.39%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

60 Degrees Pharmaceuticals Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Current Price	$4.16
Prev Close	$3.85
Open	$3.78
Dividend Yield	0.00%
50-Day Moving Average	$3.31
Beta	0.00
Avg. Volume	10.29M
PE Ratio	-0.14

52-Week High	$17.68
52-Week Low	$1.36
Market Capitalization	$4.4M
EPS (Annual)	-$74.18
Price to Book	-0.83
Revenue Per Employee	$227,115.00
Enterprise Value/EBITDA	N/A

SXTP
60 Degrees Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SXTP News

SXTP60 Degrees Pharmaceuticals Inc